Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:01 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 238 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Implantable Cardioverter Defibrillator Clear all

Conditions: Heart Failure
Interventions: Ultra Conservative ICD Programming, Traditional ICD Programming; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Defibrillators, Implantable, Heart Failure, Congestive
Interventions: Aerobic Exercise Program; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 21 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Heart Failure, Ventricular Dyssynchrony
Interventions: Implantable Cardioverter Defibrillator with Cardiac Resynchronization Therapy (BIOTRONIK Lumax HF-T CRT-D); Device
Lead sponsor: Biotronik, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,680 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 62
States / cities: Concord, California • Los Angeles, California • Rancho Mirage, California + 46 more

Conditions: Implantable Cardioverter Defibrillator (ICD)
Interventions: patient only, patient and partner intervention; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 21 Years and older
Enrollment: 301 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Ventricular Arrhythmias
Interventions: Implantable Cardioverter Defibrillator; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 24
States / cities: Little Rock, Arkansas • Glendale, California • Inglewood, California + 21 more

Conditions: Arrhythmias
Interventions: azimilide dihydrochloride; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 50
States / cities: Mobile, Alabama • Little Rock, Arkansas • La Jolla, California + 43 more

Conditions: Myocardial Infarction, Arrhythmia, Ventricular, Ischemic Cardiomyopathy
Interventions: T Wave Alternans Test; Procedure
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: Not listed
Enrollment: 405 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 47
States / cities: Mobile, Alabama • Phoenix, Arizona • Walnut Creek, California + 44 more

Conditions: Heart Failure, Obesity
Interventions: Body Composition Analysis InBody Scale; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Heart Failure, Systolic, Heart Failure
Interventions: Educational video and/or handout; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 790 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Bradycardia, Arrhythmia
Interventions: Transtelephonic monitoring (TTM), Medtronic CareLink® Network; Other
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: Not listed
Enrollment: 980 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 45
States / cities: Scottsdale, Arizona • Little Rock, Arkansas • Washington D.C., District of Columbia + 42 more

Conditions: Congestive Heart Failure, Coronary Artery Disease, Myocardial Infarction
Interventions: MyoCell™, MyoCath™; Drug · Device
Lead sponsor: Bioheart, Inc.; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 5
States / cities: Sunrise, Florida • Atlanta, Georgia • Minneapolis, Minnesota + 2 more

Conditions: Arrhythmia
Interventions: Not listed
Lead sponsor: QuesGen Systems Inc; Other
Eligibility: Not listed
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 1
States / cities: Lehi, Utah

Conditions: Arrhythmias
Interventions: Peripheral blood sampling; Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2018
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania

Conditions: Heart Failure and Reduced Ejection Fraction
Interventions: Online, patient-facing decision-making aid (app) with personalized risk information., Implantable Cardioverter Defibrillator (ICD), Online, patient-facing decision-making app without personalized risk information.; Other · Device
Lead sponsor: Stanford University; Other
Eligibility: 60 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: San Francisco, California • Greenville, North Carolina

Conditions: Defibrillators, Implantable
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Sudden Cardiac Death, Arrhythmia, Heart Failure
Interventions: Magnet or Off-On; Other
Lead sponsor: Midwest Heart Foundation; Other
Eligibility: 19 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 3
States / cities: Downers Grove, Illinois • Elmhurst, Illinois • Naperville, Illinois

Conditions: Congestive Heart Failure
Interventions: EnSite NavX System; Other
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 2
States / cities: Augusta, Georgia • Durham, North Carolina

Conditions: Focus Whether After Implant Pre-AICD Video Was Helpful
Interventions: Video/workbook for patients about to receive an AICD, LiveSkills Video/Workbook for patients about to receive an AICD; Behavioral
Lead sponsor: Williams LifeSkills; Industry
Eligibility: 21 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Arrhythmia, Quality of Life, Hypomagnesemia
Interventions: Magnesium L-lactate; Drug
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Heart Failure
Interventions: CRT-D; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 699 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 41
States / cities: Birmingham, Alabama • Huntsville, Alabama • Tucson, Arizona + 37 more

Conditions: Cardiomyopathies, Heart Failure, Non-left Bundle Branch Block, Cardiac Resynchronization Therapy
Interventions: CRT-D implantation; Procedure
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Cardiomyopathy
Interventions: Not listed
Lead sponsor: Essentia Health; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Duluth, Minnesota

Conditions: Tachycardia, Diabetes Mellitus, Cardiovascular Disease
Interventions: Subcutaneous Implantable Cardioverter Defibrillator; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 65 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 36
States / cities: Huntsville, Alabama • Scottsdale, Arizona • Jonesboro, Arkansas + 31 more

Conditions: Heart Failure
Interventions: LMI 1195-101; Drug
Lead sponsor: Lantheus Medical Imaging; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 2
States / cities: Hartford, Connecticut • New Haven, Connecticut

Search by objective public record fields.

Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).

Exercise After an ICD

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

Patient and Partner Intervention After an Implantable Cardioverter Defibrillator (ICD)

Clinical Investigation of the Medtronic EnTrust™ Implantable Cardioverter Defibrillator (ICD), Model D153ATG

Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)

MASTER II - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients

Safety of Body Composition Analysis in Heart Failure Patients With Implantable Cardioverter Defibrillators (ICDs)

A Multicenter Trial of a Shared DECision Support Intervention for Patients Offered Implantable Cardioverter-DEfibrillators

PREFER (Pacemaker Remote Follow-Up Evaluation and Review)

MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial)

Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry

Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm

Developing a Digital Aid to Improve ICD Decisions

Patient Expectations After Implantable-cardioverter Defibrillator (ICD) Implantation

Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Implantable Cardioverter Defibrillators

EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant

LifeSkills Video Training in Patients About to Receive an Automatic Implantable Cardioverter-Defibrillator (AICD)

Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.

Strategic Management to Optimize Response To Cardiac Resynchronization Therapy

Factors Associated With Response to Cardiac Resynchronization Therapy in Heart Failure Patients With Non-LBBB ECG Pattern

CRM and Fusion Beats: Effects of Progressive Fusion on Intra-left Ventricular Mechanical Function

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure